The AI Healthcare Podcast

Healthcare Thought Leader & Visiting Research Fellow at the Paragon Health Institute, Kev Coleman, highlights key considerations to watch for AI healthcare policy under a Trump 2.0 administration.To read more of Kev's research, please visit here.Stay tuned for the Paragon consolidated AI page, and Kev's paper with Michael Penina from Duke University that will be announced at a later time. For further insights, read Kev's paper "Healthcare AI Regulation: Guidelines for Maintaining Public Safety and Innovation", which can be found here. This paper examines the main challenges of AI regulation in healthcare and the second part provides guidelines to help policymakers avoid misregulation. Key Takeaways: 1. The key policy areas that must be addressed in AI healthcare policy are public safety and privacy while maintaining world leadership. AI healthcare policy will continue to evolve over the next two years. 2. AI healthcare places a greater reliance on data and post-market surveillance after approval. Implementing this new way of operating so that it does not restrict innovation and cause unnecessary costs is essential for the FDA to consider. 3. AI consists of various programming methodologies, each with different vulnerabilities depending on the context. Regulations must address subtypes of AI.*Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

Why is National Colorectal Cancer Awareness Month so important? Senior Vice President, Global Public Affairs at Guardant Health, Jenn Higgins, teaches us why. To learn more about Guardant Health, visit their website here. To learn more about Shield Cancer Screen, visit their website here. A huge thank you to Melissa Marasco of Guardant Health for scheduling and making this happen. Thank you!Key takeaways: 1. Since its inception in 2012, the goal of Guardant Health was to be the organization for the Continuum of Care, which includes people who have never had cancer, survivors, treatment, and monitoring. 2. With 50 million Americans unscreened for colorectal cancer, Shield Cancer Screen helps improve adherence and alleviates fears of screening. 3. Maximizing innovation and minimizing the regulatory burden will help companies get their technology products into the hands of patients. *Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

How can precision wellness and healthcare be made cheaper, safer, and more efficient in contrast to what is available on the market? Chief Executive Officer of EndoDNA, Len May, teaches us how it is possible. To connect with Len, find him on LinkedIn here. To learn more about EndoDna, visit their website here. To learn more about Len's coaching services, visit his website here. To listen to Len's podcast, "Everything is Personal", listen to his podcast here. To buy Len's book, purchase his book here. Key Takeaways: 1. The origin of EndoDNA started with Len's interest in plant genetics and human genomics and drove him into the precision health and wellness space in healthcare. 2. The goal of EndoDNA is to use their technology and AI to have a person's genotype to help design an individualized treatment plan that has a feedback loop that illustrates similar individuals that have undergone said individualized treatment plan, which proves it is efficacious. 3. Preventative measures are essential in reducing the cost of healthcare, such as the use of genetics and epigenetics. With the addition of AI, healthcare professionals will be able to better understand their patients, and insurance companies will reduce the burden on themselves. *Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

How do we change the stigma of addition and make sure that people get the help that they need? Executive Director of the Matthew Perry Foundation of Canada, Caitlin Morrison, teaches out how. Thank you for sharing Matthew's story with us. A huge thank you to Kayla Folo for your help in bringing the story of the Matthew Perry Foundation of Canada to the public.To learn more about the Matthew Perry Foundation of Canada, please visit their website here.Key Takeaways: 1. There is an addiction crisis and people need support, but there is not enough of it for those who are struggling. 2. AI allows us to understand more about the brain and help us find real treatments beyond just recovery so that the brain can heal itself naturally. 3. Because of the breakthroughs that AI is making in healthcare, the technology can identify genetic markers in individuals in determining those who are at risk of developing an addiction and constructing an individualized treatment plan. Comment pouvons-nous de l'addiction et aide ceux qui en ont besoin? La directrice exécutive de la Fondation de Matthew Perry de Canada, Caitlin Morrison, elle nous enseigne. Merci beaucoup en partageant l'histoire de ton frère, Matthew Perry, avec nous. Merci beaucoup á Kayla Folo pour ton soutien en partageant l'histoire de the Matthew Perry Foundation à la publique. Pour appendre de the Matthew Perry Foundation of Canada, connectez-vous ici.Les Principales Conclusions:1. Il y a une crise de l'addiction et les gens ont besoin de soutien, mais il n'y en a pas assez pour ceux qui luttent.2. L'IA nous permet de mieux comprendre le cerveau et nous aide à trouver de véritables traitements, au-delà de la simple récupération, afin que le cerveau puisse se guérir naturellement. 3. Au cause aux avancées du IA en la santé publique, la technologie peut identifier des marqueurs genetiques dés personnes en déterminant ceux qui risquent de développer une addiction et en élaborant un plan de traitement individualisé.

How do we advance the citizen and patient voice across health and healthcare while integrating AI into its operations? CEO and Board Advisor For AI and Digital Health Companies, Jon Warner, teaches us how. To connect with Jon, find him on LinkedIn here. Key Takeaways:1. All technology these days is somewhat AI-driven so it is impossible to ignore. 2. Reimbursement drives so much innovation and technologists must understand where the money flows and how it creates workflow.3. There has to be more effort invested in how to create the framework to help humanity and not hinder it.

How can we have more constructive conversations around AI healthcare policy? Former Congressman, AI Healthcare Thought Leader, and Vice Chairman of Prime Policy Group, Tom Reed, tells us how. To connect with Tom, find him on LinkedIn here. Or, follow Tom on X here. To learn more about Prime Policy Group, find their page here. Key Takeaways:1. Tom's first speech on the House Floor dealt with diabetes and was the Co-Chairman of the House Diabetes Caucus. In conjuction with the technological advancements, diabetes is a personal passion of his because of his family ties and would love to see a cure for the disease. 2. While cost is an important part of healthcare, the question that we should ask is: How do you measure good quality outcomes?3. Always know your audience and bring a solution to their problem and understand the motivations of the member. Is it to be re-elected etc...Also, the issue should apply to their district or state.

How do we make sure that areas, such as District 14 of Louisiana do not get left behind in the AI healthcare economy? State Representative, Michael Echols, teaches us what can be done. To learn more about Michael, visit his website here. For more information on Michael's radio show "Echols at 8", visit the KMLB website here. Key Takeaways: 1. Michael has always been involved with the local community, serving on non-profit boards and holding public office ranging from city councilman to state representative. 2. Louisiana is currently disjointed in its specialty medical education, but in the next 5-10 years most of the primary care voids will be filled in both the rural and urban markets of the state. 3. The main AI question that needs to be asked is: How do you protect patients' data with HIPAA while aligning fair incentives where insurance companies cannot just use AI to deny claims and figure out core disease states from those claims? * Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

How are the regulatory landscape and market compliance practiced when determining the safety of AI software that would impact healthcare globally? Digital Health Thought Leader, Rudolf Wagner, tells us how. To connect with Rudolf, connect with him on LinkedIn here. Key Takeaways:1. Germany has a two-fold regulatory environment for software as a medical device. The first is those who produce AI for clinical use, and then what happens in the hospital. 2. When a major situation occurs, there is a change to a more strict regulation. 3. Software is measured in a matter of days and not years and the current regulatory environment needs to get ahead of the market or allow people to be on their own.

How can we "create more capacity to care" with research and development on LLMs in patient-facing medical software? Emergency Medicine Physician and VP of Clinical AI of Fabric, Dr. Jon Pangia, tells us how it can be done. To connect with Dr. Pangia, please find him on LinkedIn here. To learn more about Fabric, please visit their website here. Key Takeaways:1. Fabric started with the central question of "how we can help healthcare", and then evolved to using digital healthcare as a software service for hospitals to help patients in and through the emergency department with better awareness and follow-up after their visit. 2. If physicians begin experimenting with AI, then there will be more tools to help them become better at their profession.3. Policymakers should focus on the bad actors instead of writing regulations that will become obsolete in a short amount of time.

How will AI and Digital Therapeutics role affect the Indian Healthcare System? Dr. Manthan Mehta teaches us what to expect. To connect with Dr. Mehta, connect with him here. Key Takeaways:1. Healthcare is not just about curing illnesses, but also about improving the quality of life and where you marry science and empathy. 2. Disease management must be more proactive, personalized, and accessible to support patients in navigating the healthcare system.3. Physicians play the biggest role in AI Healthcare because they are the gatekeepers and advocates for AI healthcare. AI is a tool for them and they will use those insights and apply them to patient care.

How can you make EHR integration painless? CEO & Co-Founder of Topology Health, Alex Goel, teaches us how it is possible. To connect with Alex, find him on LinkedIn here. To learn more about Topology Health, please find more here. Key Takeaways:1. Pre-Topology Health, there were not any developer-focused tools for building EHR integration into applications or other health IT systems. 2. Topology Health creates customized solutions for clients in EHR integration based on the data needs while ensuring a use-case-first perspective. 3. Provinces can implement their rules and regulations around the data privacy of Canadians.

How can one make a lateral career move from the clinical to the consulting side of healthcare? AI startup advisor and nurse, Dr. Karen B Seagraves, tells us her story of how she did it and how she sees the integration of AI in healthcare. To connect with Karen, find her on LinkedIn here. Key Takeaways:1. Having clinician, administrator, researcher, and business perspectives is crucial in deciding whether medical products/services by companies will impact the healthcare system. 2. Making the EHR accessible to nurses is essential in helping patients receive the best possible care. 3. Access to patient information is needed to help save a patient's life and provide them with a better outcome while ensuring healthier communities.

How can we usher in non-insurance wellness benefits today? Chief Growth Officer Of Well-Genie, Chris Mathew, tells us how it is possible. To connect with Chris, find him on LinkedIn here. To learn more about Well-Genie, please find more here. A huge shoutout to our mutual friend Tiffany Ryder for connecting us and making this interview happen. Thank you!Key Takeaways:1. Well-Genie is focused on generic medications, wellness tools, and the GLP-1 marketplace.2. Patient Advocacy and Navigation are essential in helping people move forward in their health journey. 3. When constructing policy for wellness benefits, the "way it's always been done" should not be the default, and we must look at this from a different perspective and new information.

How can we use AI to reduce medical supply costs and decrease order times in the healthcare supply chain? Chief Executive Officer of Grapevine Medical Supply & Procurement, Luká Yancopoulos, educates us on how it is possible. To connect with Luká , find him on LinkedIn here.To learn more about Grapevine Medical Supply & Procurement, please find more here.A huge shoutout to Adrienne Uthe of Kronus Communications for scheduling and making this interview happen. Thank you!To learn more about Kronus, please find more here. Key Takeaways:1. The origin of Grapevine came from Luka's desire to contribute to a solution that his parents were facing while they were at risk taking care of patients during COVID.2. Diversifying spend among suppliers and creating a more competitive marketplace decreases costs and saves time. 3. 1/2 trillion is spent on medical supplies and pharmaceuticals and Grapevine aims to cut that in half in the near term across all medical practices.

What is the story behind the Hevolution Foundation? Chief Executive Officer, Dr. Mehmood Khan, educates us on how the organization is addressing the increasing rates of age-related disabilities and diseases while advancing science. To connect with Dr. Khan, find him on LinkedIn here.To learn more about Hevolution Foundation, find their website here, A huge shoutout to the APCO and Hevolution teams for scheduling and making this happen. Thank you!Key Takeaways:1. The Hevolution Foundation was created by a royal order to address the huge, worldwide demographic change, including the significant healthcare and global economic burden. 2. The mission and vision of the Hevolution Foundation aim to answer how do you democratize the extension of a healthy life span for all.3. World leaders must look at the fields of aging biology and geroscience in the following three ways:I. Aging and the demographic changes it has on society should be a high priority for every world leader.II. How we can better address the field of geroscience.III. The compression of the time period that people live with disease.

Why should healthspan technologies be a priority for investors? Chief Investment Officer of Hevolution Foundation, Dr. William Greene tells us why. To connect with Dr. Greene, find him on LinkedIn here. To learn more about Hevolution Foundation, find their website here. A huge shoutout to the APCO and Hevolution teams for scheduling and making this happen. Thank you! Key Takeaways:1. The solution to solving chronic diseases in aging populations lies in addressing the technological, care, and approach gaps. 2. About 5% of people globally develop cancer in their lifetime and 100% of people develop chronic, debilitating diseases, which demonstrates that the market for healthspan technologies is vast and underserved. 3. Thinking holistically from idea, science, and then translation is essential in the cause and treatment of diseases for patients.

How can we empower and integrate no-code platforms in AI, APIs, and data sources? Chief Marketing Officer of SmythOS, Michael Walker II, educates us on its possibilities. To connect with Michael, find him on LinkedIn here.To learn more about SmythOS, please find more here.A huge shoutout to Adrienne Uthe of Kronus Communications for scheduling and making this interview happen. Thank you!To learn more about Kronus, please find more here. Key Takeaways:1. As AI advances, the technology becomes more user-friendly. 2. SmythOS aims to be the happy medium between GPTs and customized AI solutions. 3. Oversight regulatory bodies are necessary because AI is here and it is not going anywhere.

What is the current state of the healthcare system in Nigeria and how is the country spurring innovation in Africa? Medical Student at Ambrose Alli University, Abraham Obianke, educates us on what is being done. To connect with Abraham, find him on LinkedIn here. Key Takeaways:1. Nigeria has a shortage of medical professionals because they are not well-compensated. The lack of compensation compels doctors to move to other areas, which include the United Kingdom and the United States. 2. In an average medical school class in Nigeria, 70% of graduates will move to other parts of the world where their skills are more valued. 3. Because of the lack of modern medical equipment and government policies that encourage public health initiatives, Nigeria has expedited the use of technology in its healthcare system.

How do we prevent health professional burnout AND break down barriers for patients to communicate with providers globally while being patient-centric in the process? Founder & CEO of Upvio, Mark Evans, teaches us how it is possible.A huge shoutout to Robert Winkelmann, for scheduling and making this interview happen! Thank you!To connect with Mark, visit him on LinkedIn here. To learn more about Upvio, visit their website here.Key takeaways:1. Part of the story of Upvio aims to solve the question of "why should we be restricted by the locality that we are in" by breaking down barriers for patients to communicate globally with the best medical professionals to receive the best care possible. 2. Many big healthcare providers in Australia (with large, global teams) use U.S.-facing EHRs, which is the main clientele of Upvio's business. 3. Upvio is moving towards "Emotional", "Conversational", and "Empathic" AI, which is the ability to do virtual consultations and monitor the facial expressions of the patient/person, the tonality and intonation of the patient's/person's voice, and how they react to a question. All of these features would be summarized into a note that can be saved to their patient record.

What is "systematic selling" and how does it translate to being successful in sales, such as in the AI Healthcare space? Founder and CEO of Systematic Selling and Host of the Systematic Selling Podcast, Sean Lyden, educates us on how it is possible. To connect with Sean, visit him on Linkedin here: https://www.linkedin.com/in/seanlyden/Subscribe to the Systematic Newsletter here: https://www.systematicselling.co/Listen to the Systematic Selling Podcast here: https://www.systematicselling.co/podcastBuy a copy of Collaboration Effect on Profit: Overcoming Founder's Syndrome to Achieve Sustainable Success here: https://www.amazon.com/Collaboration-Effect-Profit-Overcoming-Sustainable/dp/B0CZ89TN8P/ref=sr_1_1?dib=eyJ2IjoiMSJ9.gE6SiUPWZSqQV2TMTUbEwIoJ_-NgkSiJFD_nL_IB7-A.EQlXs fjMz6njNv_JWdTiUt1YArudvefq2viyWXocwI&dib_tag=se&keywords=Sean+M.+Lyden&qid=1728151430&s=audible&sr=1-1-catcorrKey Takeaways:1. Systematic selling takes a systematic and intentional approach, ranging from a company's sales system to developing sales talent into a high-performing team. 2. The right systems will allow organizations to reach their fullest potential. 3. Sales and Relationship Building is ranked by a trust continuum from 0-10 (0 being untrustworthy and 10 being impeccable trust).